Approval of income statement and balance sheet for the financial year 2023 and discharge from liability
The annual shareholders' meeting approved the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2023, and the members of the board and the CEO were discharged from liability for the financial year 2023.
Allocation of profit or loss
The annual shareholders' meeting resolved, in accordance with the board of directors' proposal, on a dividend to the shareholders of
Election of board members, auditors, fees to the board of directors and auditors
The annual shareholders' meeting resolved, in accordance with the nomination committee's proposal, that the number of members of the board of directors shall be seven without deputy members, and that the company shall have a registered public accounting firm as auditor.
In accordance with the nomination committee's proposal,
The annual shareholders' meeting further resolved, in accordance with the nomination committee's proposal, that the fees to board, including fees for work in committees, shall be
The inaugural meeting of the board of directors resolved to re-elect
Nomination committee for the annual shareholders' meeting 2025
The annual shareholders' meeting resolved, in accordance with the nomination committee's proposal, to adopt principles for the appointment of the nomination committee for the annual shareholders' meeting 2025. In short, the nomination committee shall consist of the chairman of the board of directors and members appointed by the four largest shareholders, in terms of votes, as of
Approval of the board of directors' remuneration report
The annual shareholders' meeting approved the board of directors' remuneration report.
Guidelines for remuneration to senior executives and members of the board of directors
The annual shareholders' meeting resolved, in accordance with the board of directors' proposal, to adopt guidelines for remuneration to senior executives and members of the board of directors.
Authorisation to issue new shares
The annual shareholders' meeting resolved to, in accordance with the board of directors' proposal, authorise the board of directors to resolve - at one or several occasions and for the time period until the next annual shareholders' meeting - to increase the company's share capital by new share issues, to the extent that it corresponds to a dilution of not more than 10 percent of the number of shares outstanding at the time of the notice of the annual shareholders' meeting after full exercise of the authorisation. New share issues may be made with or without deviation from the shareholders' preferential rights and with or without provisions for contribution in kind, set-off or other conditions.
Authorisation to repurchase and transfer own shares
The annual shareholders' meeting resolved to, in accordance with the board of directors' proposal, authorise the board of directors to resolve on repurchase and transfer of own class B shares.
Additional information from the annual shareholders' meeting
The presentation made by CEO
FOR MORE INFORMATION, PLEASE CONTACT:
Liia Nõu, vd, +46 (8) 506 205 50
The information was submitted for publication at
About
https://news.cision.com/pandox/r/press-release-from-the-annual-shareholders--meeting-in-pandox-aktiebolag--publ--on-10-april-2024,c3959343
https://mb.cision.com/Main/3642/3959343/2722473.pdf
(c) 2024 Cision. All rights reserved., source